Leggett J
Tex Heart Inst J. 1990; 17(4):330-6.
PMID: 15227525
PMC: 324943.
Bucaneve G, Menichetti F, Del Favero A
Pharmacoeconomics. 1999; 15(1):85-95.
PMID: 10345160
DOI: 10.2165/00019053-199915010-00006.
De Lalla F
Drugs. 1997; 53(5):789-804.
PMID: 9129866
DOI: 10.2165/00003495-199753050-00005.
Daum R, Nachman J, Leitch C, Tenover F
J Clin Microbiol. 1994; 32(1):246-8.
PMID: 8126192
PMC: 263009.
DOI: 10.1128/jcm.32.1.246-248.1994.
Rains C, Bryson H, Peters D
Drugs. 1995; 49(4):577-617.
PMID: 7789291
DOI: 10.2165/00003495-199549040-00008.
Univariate and multivariate analyses of risk factors predisposing to auditory toxicity in patients receiving aminoglycosides.
Gatell J, FERRAN F, Araujo V, Bonet M, Soriano E, Traserra J
Antimicrob Agents Chemother. 1987; 31(9):1383-7.
PMID: 3674849
PMC: 174947.
DOI: 10.1128/AAC.31.9.1383.
Transplant infections--controversies about cost related issues.
Young L, Bermudez M
Bull N Y Acad Med. 1987; 63(6):452-62.
PMID: 3479204
PMC: 1629379.
Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures.
COUNTS G, Schwartz R, Ulness B, Hamilton D, Rosok M, Cunningham M
J Clin Microbiol. 1988; 26(6):1161-5.
PMID: 3133390
PMC: 266554.
DOI: 10.1128/jcm.26.6.1161-1165.1988.
Prospective randomized clinical trial of teicoplanin for empiric combined antibiotic therapy in febrile, granulocytopenic acute leukemia patients.
Del Favero A, Menichetti F, Guerciolini R, Bucaneve G, Baldelli F, Aversa F
Antimicrob Agents Chemother. 1987; 31(7):1126-9.
PMID: 2959198
PMC: 174882.
DOI: 10.1128/AAC.31.7.1126.
Neutropenia: antibiotic combinations for empiric therapy.
Young L
Eur J Clin Microbiol Infect Dis. 1989; 8(2):118-22.
PMID: 2498091
DOI: 10.1007/BF01963893.
Ceftriaxone versus aztreonam plus cefazolin for infections in cancer patients with adequate neutrophil counts.
Menichetti F, Del Favero A, Bucaneve G, Minotti V, Patoia L, PAULUZZI S
Infection. 1990; 18(3):166-9.
PMID: 2365468
DOI: 10.1007/BF01642106.
Treatment of severe sepsis in bone marrow transplant recipients with teicoplanin in combination with beta-lactams and aminoglycosides.
Fauser A, Lang E, Dolken G, Bross K, Schmid J, Sorgel F
Infection. 1991; 19(3):195-200.
PMID: 1832419
DOI: 10.1007/BF01643253.
Antimicrobial agent therapy for Pseudomonas aeruginosa.
Korvick J, Yu V
Antimicrob Agents Chemother. 1991; 35(11):2167-72.
PMID: 1803987
PMC: 245354.
DOI: 10.1128/AAC.35.11.2167.
Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
Maiche A, Teerenhovi L
Infection. 1991; 19 Suppl 6:S326-9.
PMID: 1791078
DOI: 10.1007/BF01715773.
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Feliu J, Artal A, Gonzalez Baron M, Berrocal A, Chacon I, Garcia de Paredes M
Antimicrob Agents Chemother. 1992; 36(12):2816-20.
PMID: 1482151
PMC: 245551.
DOI: 10.1128/AAC.36.12.2816.
